Value-based drug pricing in the Biden era: Opportunities and prospects.

Szczegóły

Tytuł:: Value-based drug pricing in the Biden era: Opportunities and prospects.
Autorzy:: Neumann PJ; Center for the Evaluation of Value and Risk in Health, Tufts University School of Medicine, Boston, Massachusetts, USA.
Ollendorf DA; Center for the Evaluation of Value and Risk in Health, Tufts University School of Medicine, Boston, Massachusetts, USA.
Cohen JT; Center for the Evaluation of Value and Risk in Health, Tufts University School of Medicine, Boston, Massachusetts, USA.
Źródło:: Health services research [Health Serv Res] 2021 Dec; Vol. 56 (6), pp. 1093-1099. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: Malden, MA : Blackwell
Original Publication: Chicago, Hospital Research and Educational Trust.
MeSH Terms:: Costs and Cost Analysis*
Drug Costs*
Value-Based Purchasing*
Drug Industry/*economics
Drugs, Generic/economics ; Global Health ; Humans ; United States
References:: JAMA. 2018 Jun 26;319(24):2473-2474. (PMID: 29800152)
J Manag Care Spec Pharm. 2015 Apr;21(4):269-75. (PMID: 25803760)
J Health Econ. 1997 Feb;16(1):1-31. (PMID: 10167341)
Pharmacoeconomics. 2018 Feb;36(2):239-252. (PMID: 29273843)
JAMA. 2019 May 28;321(20):2025-2027. (PMID: 31135837)
Health Econ. 2013 Aug;22(8):948-64. (PMID: 22961976)
Ann Health Law. 2010 Winter;19(2):311-65, preceding i. (PMID: 21443147)
Value Health Reg Issues. 2017 Dec;14:20-27. (PMID: 29254537)
P T. 2019 May;44(5):234-266. (PMID: 31080330)
Issue Brief (Commonw Fund). ;2017:1-14. (PMID: 28990747)
Soc Sci Med. 1995 Nov;41(10):1429-37. (PMID: 8560311)
N Engl J Med. 2014 Aug 28;371(9):796-7. (PMID: 25162885)
N Engl J Med. 2012 Nov 8;367(19):1775-7. (PMID: 23113832)
Pharmacoeconomics. 2020 Oct;38(10):1135-1145. (PMID: 32696192)
Health Aff (Millwood). 2018 Jul;37(7):1041-1047. (PMID: 29985695)
Health Aff (Millwood). 2019 May;38(5):804-811. (PMID: 31059372)
Health Serv Res. 2021 Dec;56(6):1093-1099. (PMID: 34085289)
Value Health. 2016 Jul-Aug;19(5):558-66. (PMID: 27565273)
Value Health. 2019 Dec;22(12):1396-1401. (PMID: 31806196)
Med Care. 2008 Apr;46(4):349-56. (PMID: 18362813)
NCHS Data Brief. 2015 Jan;(184):1-8. (PMID: 25633356)
Health Aff (Millwood). 2007 Mar-Apr;26(2):w195-203. (PMID: 17264100)
Am J Prev Med. 2001 Apr;20(3 Suppl):36-43. (PMID: 11306230)
N Engl J Med. 2019 Oct 10;381(15):1404-1406. (PMID: 31483959)
Health Aff (Millwood). 2021 Jan;40(1):53-61. (PMID: 33211534)
Ann Intern Med. 2018 Mar 20;168(6):436-437. (PMID: 29435565)
Value Health. 2016 Dec;19(8):929-935. (PMID: 27987642)
JAMA. 2016 Feb 2;315(5):461-2. (PMID: 26747694)
JAMA Intern Med. 2016 Sep 1;176(9):1391-3. (PMID: 27428055)
Value Health. 2018 Feb;21(2):169-170. (PMID: 29477396)
Health Econ. 2015 Oct;24(10):1289-1301. (PMID: 25070495)
Health Econ. 2019 Jan;28(1):87-100. (PMID: 30273967)
Am J Manag Care. 2006 Jan;12(1):30-6. (PMID: 16402886)
Med Decis Making. 2000 Jul-Sep;20(3):332-42. (PMID: 10929856)
JAMA. 2016 Aug 23-30;316(8):858-71. (PMID: 27552619)
Ann Intern Med. 2017 Sep 19;167(6):432-433. (PMID: 28847014)
Med Decis Making. 2010 Jul-Aug;30(4):E14-27. (PMID: 20551473)
Milbank Q. 2017 Sep;95(3):554-601. (PMID: 28895227)
Value Health. 2010 Sep-Oct;13(6):857-9. (PMID: 20701730)
Health Policy. 2019 Feb;123(2):182-190. (PMID: 28420539)
Value Health. 2017 Feb;20(2):206-212. (PMID: 28237196)
Value Health. 2019 Jul;22(7):785-791. (PMID: 31277825)
Neurology. 2015 May 26;84(21):2185-92. (PMID: 25911108)
Eur J Health Econ. 2019 Jul;20(5):751-762. (PMID: 30796552)
Substance Nomenclature:: 0 (Drugs, Generic)
Entry Date(s):: Date Created: 20210604 Date Completed: 20211207 Latest Revision: 20231108
Update Code:: 20240105
PubMed Central ID:: PMC8586482
DOI:: 10.1111/1475-6773.13686
PMID:: 34085289
: Czasopismo naukowe

Pełny tekst

Informacja